Related Experiment Video
Updated: Aug 9, 2026
11:07
Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
90 years on: a therapy to 'stimulate the phagocytes'?
1Immunobiology Unit, Institute of Child Health, University College London Medical School, UK.
Scandinavian Journal of Immunology
|August 26, 1998
Summary
Mannan-binding lectin (MBL) deficiency, caused by gene mutations, increases infection and autoimmune disease risks. MBL replacement therapy shows promise as a safe and practical treatment, needing further large-scale trials.
Area of Science:
- Immunology
- Genetics
Background:
- Collectins, including mannan-binding lectin (MBL), are key components of the innate immune system.
- MBL deficiency, often due to specific gene mutations, is linked to increased susceptibility to infections and autoimmune disorders.
Discussion:
- Three point mutations in the MBL gene's exon 1 disrupt protein structure, likely hindering oligomer assembly.
- Studies indicate a correlation between MBL deficiency and heightened risk of various infections and autoimmune conditions.
Key Insights:
- MBL acts as a bridge between innate and adaptive immunity.
- Functional MBL deficiency presents as a common opsonic defect.
Outlook:
- Initial MBL replacement therapy trials suggest safety and practicality.
- Larger clinical trials are necessary to confirm the efficacy of MBL therapy.
